Malignant Hemangiopericytoma — Trials

Malignant Hemangiopericytoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00346164	Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	completed	Phase 3	588	Children's Oncology GroupNETWORK	5	Apr 28, 2022	clinicaltrials
NCT01532687	Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma	completed	Phase 2	54	OHSU Knight Cancer InstituteOTHER	1	Sep 27, 2021	clinicaltrials
NCT00112463	Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma	completed	Phase 2	40	National Cancer Institute (NCI)NIH	0	Jun 14, 2017	clinicaltrials
NCT00720174	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma	completed	Phase 1	30	National Cancer Institute (NCI)

Data updated 22 days agoSource updated Apr 28, 2022source: clinicaltrials